BRTX vs USB · rev $401.0K vs P/E 12, rev $28.66B
BioRestorative Therapies Inc (BRTX) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
BRTX currently screens at market cap $10.2M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the BRTX and USB stock pages for the full models.
Not investment advice.